These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14962162)

  • 1. Screening and cognitive impairment: ethics of forgoing mammography in older women.
    Raik BL; Miller FG; Fins JJ
    J Am Geriatr Soc; 2004 Mar; 52(3):440-4. PubMed ID: 14962162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms.
    Mack DS; Lapane KL
    J Womens Health (Larchmt); 2019 Jun; 28(6):820-826. PubMed ID: 30625008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision-Making Regarding Mammography Screening for Older Women.
    Schonberg MA
    J Am Geriatr Soc; 2016 Dec; 64(12):2413-2418. PubMed ID: 27917463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cognitive impairment on screening mammography use in older US women.
    Mehta KM; Fung KZ; Kistler CE; Chang A; Walter LC
    Am J Public Health; 2010 Oct; 100(10):1917-23. PubMed ID: 20075325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision-making about mammographic screening: pursuing informed choice.
    Hersch J; Jansen J; McCaffery K
    Climacteric; 2018 Jun; 21(3):209-213. PubMed ID: 29419315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening. Benefits, harms, and informed choice.
    Jørgensen KJ
    Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed decision making: age of 50 is arbitrary and has no demonstrated influence on breast cancer screening in women.
    Kopans DB
    AJR Am J Roentgenol; 2005 Jul; 185(1):177-82. PubMed ID: 16060005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
    Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
    Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Irwig L; McGeechan K; Jacklyn G; Thornton H; Dhillon H; Houssami N; McCaffery K
    Lancet; 2015 Apr; 385(9978):1642-52. PubMed ID: 25701273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient factors associated with breast cancer screening among older women.
    Marwill SL; Freund KM; Barry PP
    J Am Geriatr Soc; 1996 Oct; 44(10):1210-4. PubMed ID: 8856000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician over-recommendation of mammography for terminally ill women.
    Leach CR; Klabunde CN; Alfano CM; Smith JL; Rowland JH
    Cancer; 2012 Jan; 118(1):27-37. PubMed ID: 21681736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIH Consensus Statement. Breast cancer screening for women ages 40-49.
    NIH Consens Statement; 1997 Jan 21-23; 15(1):1-35. PubMed ID: 9267441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.